| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0008 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |